Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience
Accel Instruments and GSI (Gesellschaft fur Schwerionenforschung) are partnering with Siemens Medical Solutions to develop technology for delivering particle therapy. Accel, headquartered in Bergisch Gladbach, Germany, has more than 20 years' experience in particle accelerator technology. GSI is a government-funded heavy ion research center located in Darmstadt, Germany. Particle therapy treatments utilize fast-moving atomic particles such as ions or protons. Treatments can be focused with pinpoint accuracy, thereby lowering integral dose and reducing toxicity to healthy tissues.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.